Livzon Pharmaceutical Group (HK:1513) has released an update.
Livzon Pharmaceutical Group Inc. has announced the complete cancellation of a significant number of share options under its 2022 Share Options Incentive Scheme. A total of 6,283,750 share options have been cancelled following verification by the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. This move aligns with the company’s previously disclosed intentions and has been fully executed as of May 27, 2024.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
